Picture of Astec Lifesciences logo

ASTEC Astec Lifesciences Income Statement

0.000.00%
in flag iconLast trade - 00:00
Basic MaterialsAdventurousSmall CapNeutral

Annual income statement for Astec Lifesciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

2019
March 31st
2020
March 31st
2021
March 31st
2022
March 31st
2023
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IAS
IAS
IAS
IAS
IAS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue4,3095,2265,5496,7666,282
Cost of Revenue
Gross Profit1,2371,4761,7812,3691,695
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses3,7374,6044,6905,5695,850
Operating Profit5726228591,197431
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes5596148911,211349
Provision for Income Taxes
Net Income After Taxes358475651899256
Minority Interest
Net Income Before Extraordinary Items
Net Income357475650899256
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income357475650899256
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS18.324.333.245.813.2
Dividends per Share